Last reviewed · How we verify

NCT03618979

A Trial Comparing Three Orthobiologic Therapies on Atrophied Multifidus Muscles in Patients With Low Back Pain

Terminated NA Last updated 8 July 2022
What this trial tests

NA trial testing PPP treatment in Low Back Pain in 8 participants. Terminated before completion.

Timeline
2 May 2019
Primary endpoint
29 June 2022
29 June 2022

Quick facts

Lead sponsorRegenexx, LLC
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment8
Start date2 May 2019
Primary completion29 June 2022
Estimated completion29 June 2022
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Regenexx, LLC — full company profile →

Who can join

Adults 18 to 75, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate and compare the effectiveness of 3 different injection treatments on multifidus atrophy and lower back pain.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Biomimetic Scaffolds in Skeletal Muscle Regeneration.
    Mulbauer GD, Matthew HWT. · · 2019 · cited 28× · PMID 32309608 · DOI 10.15190/d.2019.3

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other Regenexx, LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03618979.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing